Today is December 30, just two days away from 2022. Just as this year's Hong Kong stock market comes to a fresh end, there are some highlights. Quanfeng Holdings closed up 28.44%, Shangtang-W rose 7.27%, and Shengnuo Pharmaceutical-B rose 18.21%. It was rare to see three consecutive IPOs. What is most rare is that Quanfeng Holdings is the only large stock in the past six months that was a red market and did not turn green on the first day of the dark market. The increase was more than 30%. The last one probably dates back to when Conoa-B was listed on July 2.
The other two, Shangtang and Shengnuo Pharmaceuticals, have repeatedly postponed the Hong Kong stock listing plan, and the artificial intelligence bubble has long since burst. The story has long since been impossible to tell. The capital was not approved for a long time. The listing was actually a helpless move. Obviously, it is not easy to raise money. Recently, the entire sector of Shengnuo Pharmaceutical-b and Class B pharmaceutical stocks has experienced a disastrous decline. Just a few days ago, Kaituo Pharmaceutical also fell 80%. Everyone has already talked about changes in medicine, and today there can still be a 20% increase.
There are few people playing around with IPOs now, and there is little pressure. If the national distribution side is fixed, it's still easy to flock around. If there are too many people involved, it's probably not that fun. Earning money will always belong to a small group of people, and the rules in the stock market will always be there, so don't regret that you didn't hit anything on this ticket.
In the past six months, none of the tickets with a market value of more than 5 billion dollars increased by more than 30% on the first day, so Helens, which went public in September, was able to touch it...